サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750667

神経血管内コイルの世界市場：市場規模・シェア・動向分析 (種類別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Neuroendovascular Coil Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
神経血管内コイルの世界市場：市場規模・シェア・動向分析 (種類別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年05月16日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経血管内コイルの市場規模と動向：

世界の神経血管内コイルの市場規模は、2024年に10億4,000万米ドルと推定され、2025年から2030年にかけてCAGR 6.5％で成長すると予測されています。

この成長の背景には、高齢化や高血圧、喫煙、糖尿病などの生活習慣に関連する危険因子によって、脳動脈瘤や脳卒中の発生率が増加していることがあります。

技術の進歩により、次世代の着脱式、ハイドロゲル被覆、3D複合コイルの開発など、手技の有効性と安全性が大幅に向上しています。NIH 2025のデータによると、米国では毎年推定79万5,000人が脳卒中を経験しており、そのうち約61万人が初発です。脳卒中生存者のほぼ4人に1人は、その後も脳卒中を発症します。全脳卒中症例のうち、約87％は虚血性脳卒中に分類され、残りの13％は出血性脳卒中です。

高齢化社会は、高齢者に多い動脈瘤などの神経疾患の有病率が高いため、神経血管内コイル市場を大きく牽引しています。高齢者人口が増加するにつれて、神経血管内コイル塞栓術のような低侵襲治療に対する需要が増加します。こうした治療は、従来の手術よりも安全で回復が早いからです。さらに、高齢患者では動脈瘤の破裂や脳卒中などの合併症のリスクが高いため、神経血管内コイルに対する需要がさらに高まっています。世界のヘルスケアシステムは高齢化社会のニーズに適応し、治療リソースを増やし、有利な償還政策を打ち出しており、市場拡大に貢献しています。さらに、高齢者のQOL（生活の質）向上に注力することで、神経血管内コイルなどの高度で低侵襲な選択肢に対する需要が高まり、市場の成長に寄与しています。

下のグラフは、OECD加盟各国の2050年までの65歳以上人口比率の予測データであり、世界の高齢化動向を浮き彫りにしています。韓国（39.8%）、日本（37.7%）、イタリア（33.7%）などの国々は、高齢者の割合が最も高くなると予想されており、平均寿命の伸びと出生率の低下によって人口動態が急速に変化していることを示しています。さらに、高齢化とともに脳卒中などの疾患の発生率が上昇することが予想されるため、神経血管内コイルなど加齢に関連した医療介入や技術に対する需要が高まっていることを示しています。

高血圧は、脳動脈瘤、脳卒中、その他の脳血管異常を含む様々な血管疾患の最も重要な危険因子の一つです。世界的にその有病率が高まっていることが、神経血管内コイル市場の拡大を促す重要な要因となっています。神経血管内コイルは脳動脈瘤や血管奇形の治療に広く使用されており、これらはコントロールされていない高血圧によって引き起こされたり悪化したりしています。高血圧は出血性脳卒中の主な原因です。高血圧は動脈の狭窄や硬化を助長し、閉塞や破裂を起こしやすくします。コイルの使用を含む神経血管内治療法は、動脈瘤の破裂による出血性脳卒中に対する最前線の治療法です。世界の高血圧の負担増、特に血圧管理が不十分な低・中所得国における高血圧の負担増は、脳卒中患者の増加につながると予想され、神経血管内治療に対する需要を促進しています。英国心臓財団BHF（2025年）によると、英国の成人の約30％、約1,600万人が高血圧とともに生活しており、その半数までが有効な治療を受けていないと推定されています。約1,100万人がかかりつけの開業医の診断を受けている一方で、最大500万人の成人が未診断のままである可能性を示唆しています。合計すると、英国では最大800万人が、診断されていない、あるいはコントロールされていない高血圧を抱えて生活している可能性があります。

脳の動脈瘤は、血管が弱って膨らみを形成することで発生するもので、高齢化社会における重大な懸念事項です。動脈瘤のリスクは年齢とともに、特に50歳以降に増加します。高齢者の数が世界的に増加するにつれて、動脈瘤の発生はより一般的になり、治療の選択肢に対する需要が高まっています。神経血管内コイルはこれらの動脈瘤を治療するための好ましい方法の一つであり、従来の手術よりも侵襲的な手技を必要としないため、他の健康上の懸念があったり、侵襲的な手技の候補とならなかったりする高齢患者に適しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 神経血管内コイル市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
    • 市場機会の分析
    • 市場の課題の分析
  • ビジネス環境分析
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 神経血管内コイル市場：種類別のビジネス分析

  • 市場シェア：種類別 (2024年・2030年)
  • 種類別ダッシュボード
  • 市場規模の予測と動向分析：種類別 (2018～2030年)
  • ベアプラチナコイル
  • ハイドロゲルコーティングコイル

第5章 神経血管内コイル市場：用途別のビジネス分析

  • 市場シェア：用途別 (2024年・2030年)
  • 用途別ダッシュボード
  • 市場規模の予測と動向分析：用途別 (2018～2030年)
  • 脳梗塞
  • 脳動脈瘤
  • 動静脈奇形（AVM）
  • その他

第6章 神経血管内コイル市場：最終用途別のビジネス分析

  • 市場シェア：最終用途別 (2024年・2030年)
  • 最終用途別ダッシュボード
  • 市場規模の予測と動向分析：最終用途別 (2018～2030年)
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第7章 神経血管内コイル市場：地域別の推定と動向分析 (技術別・最終用途別)

  • 市場シェア：地域別 (2024年・2030年)
  • 市場ダッシュボード：地域別
  • 市場規模の予測と動向分析 (2018～2030年)
  • 北米
    • 国別（2018～2030年）
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別（2018～2030年）
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別（2018～2030年）
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別（2018～2030年）
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別（2018～2030年）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参入企業の概要
  • 企業シェア分析（2024年）
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Penumbra, Inc
    • TERUMO CORPORATION
    • Kaneka Medical Europe NV
    • Stryker
    • Lepu Medical Technology（Beijing）Co.,Ltd
    • Balt
    • NeuroSafe Medical Co., Ltd.
    • Johnson &Johnson
    • Boston Scientific Corporation
    • Medtronic
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global neuroendovascular coil market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 10 North America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 13 U.S. neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Mexico neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 30 France neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 31 France neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Italy neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Spain neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 43 Denmark neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 45 Sweden neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 46 Sweden neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 55 China neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 56 China neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 58 India neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 59 India neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 60 India neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 67 Thailand neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 68 Thailand neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Thailand neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 72 Latin America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Latin America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Brazil neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Argentina neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 86 South Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 92 UAE neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait neuroendovascular coil market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuroendovascular coil market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Neuroendovascular coil market dynamics
  • Fig. 13 Neuroendovascular coil market: Porter's five forces analysis
  • Fig. 14 Neuroendovascular coil market: PESTLE analysis
  • Fig. 15 Neuroendovascular coil market: Type segment dashboard
  • Fig. 16 Neuroendovascular coil market: Type market share analysis, 2024 & 2030
  • Fig. 17 Bare platinum coils market, 2018 - 2030 (USD Million)
  • Fig. 18 Hydrogel-coated coils market, 2018 - 2030 (USD Million)
  • Fig. 19 Neuroendovascular coil market: Application segment dashboard
  • Fig. 20 Neuroendovascular coil market: Application market share analysis, 2024 & 2030
  • Fig. 21 Cerebral infarction market, 2018 - 2030 (USD Million)
  • Fig. 22 Cerebral aneurysm market, 2018 - 2030 (USD Million)
  • Fig. 23 Arteriovenous Malformation (AVM) market, 2018 - 2030 (USD Million)
  • Fig. 24 Neuroendovascular coil market: End use segment dashboard
  • Fig. 25 Neuroendovascular coil market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 28 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Neuroendovascular coil market revenue, by region
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 75 MEA neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company share analysis, 2024
  • Fig. 86 Strategic framework
目次
Product Code: GVR-4-68040-577-1

Neuroendovascular Coil Market Size & Trends:

The global neuroendovascular coil market size was estimated at USD 1.04 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. This growth is attributed to the increasing incidence of cerebral aneurysms and strokes, fueled by aging populations and lifestyle-related risk factors such as hypertension, smoking, and diabetes.

Technological advancements have significantly enhanced procedural efficacy and safety, including developing next-generation detachable, hydrogel-coated, and 3D complex coils. According to the data by NIH 2025, each year, an estimated 795,000 people in the U.S. experience a stroke, with approximately 610,000 of these being first-time occurrences. Nearly one in four stroke survivors will suffer a subsequent stroke. Among all stroke cases, about 87% are classified as ischemic strokes, while the remaining 13% are hemorrhagic strokes.

The aging population significantly drives the neuroendovascular coil market due to the higher prevalence of neurological conditions, such as aneurysms, which are more common in older adults. As the elderly population grows, the demand for minimally invasive treatments, such as neuroendovascular coil embolization, increases, as these procedures are safer and involve quicker recovery than traditional surgery. Additionally, the higher risk of complications in older patients, such as aneurysms bursting or strokes, further boosts the demand for neuroendovascular coils. Healthcare systems worldwide are adapting to the needs of aging populations, increasing treatment resources, and creating favorable reimbursement policies, which helps expand the market. Moreover, the focus on improving the quality of life for elderly individuals enhances the demand for advanced, minimally invasive options such as neuroendovascular coils, contributing to the market's growth.

The below graph presents projected data on the proportion of the population aged 65 and older across various OECD countries by the year 2050, highlighting the global trend of population aging. Countries such as South Korea (39.8%), Japan (37.7%), and Italy (33.7%) are expected to have the highest percentages of elderly individuals, indicating rapid demographic shifts driven by increased life expectancy and declining birth rates. Additionally, it indicates a growing demand for age-related medical interventions and technologies, such as neuroendovascular coils, as the incidence of conditions such as stroke is expected to rise with the aging demographic.

Hypertension is one of the most significant risk factors for a variety of vascular diseases, including cerebral aneurysms, strokes, and other cerebrovascular abnormalities. Its growing prevalence globally is a critical factor driving the expansion of the neuroendovascular coil market. Neuroendovascular coils are widely used in the treatment of brain aneurysms and vascular malformations, which are caused or exacerbated by uncontrolled hypertension. Hypertension is the leading cause of hemorrhagic strokes. It contributes to the narrowing and hardening of arteries, making them more susceptible to blockage or rupture. Neuroendovascular procedures, including the use of coils, are a frontline treatment for hemorrhagic strokes caused by ruptured aneurysms. The increasing global burden of hypertension, especially in low- and middle-income countries where blood pressure control is insufficient, is expected to lead to a rise in stroke cases, thereby propelling the demand for neuroendovascular interventions. According to the British Heart Foundation BHF, 2025, it is estimated that around 30% of UK adults, approximately 16 million people, are living with high blood pressure, and up to half of them are not receiving effective treatment. While about 11 million individuals have been diagnosed by their general practitioner, this suggests that up to 5 million adults may remain undiagnosed. In total, up to 8 million people in the UK could be living with undiagnosed or uncontrolled high blood pressure.

Aneurysms in the brain, which occur when blood vessels weaken and form a bulge, are a significant concern among the aging population. The risk of aneurysms increases with age, particularly after age 50. As the number of elderly individuals rises globally, the occurrence of aneurysms has become more prevalent, fueling demand for treatment options. Neuroendovascular coils are one of the preferred methods for treating these aneurysms, as they involve less invasive techniques than traditional surgery, making them more suitable for elderly patients who may have other health concerns or are not candidates for more invasive procedures.

Global Neuroendovascular Coil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global neuroendovascular coil market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Bare Platinum Coils
  • Hydrogel-Coated Coils
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cerebral Infarction
  • Cerebral Aneurysm
  • Arteriovenous Malformation (AVM)
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neuroendovascular Coil Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of cerebral aneurysms and stroke
      • 3.2.1.2. Growing preference for minimally invasive procedures
      • 3.2.1.3. Technological advancements in coil design
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Risk of recurrence or incomplete occlusion
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Expansion in emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Regulatory and clinical trial complexities
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuroendovascular Coil Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Bare Platinum Coils
    • 4.4.1. Bare Platinum Coils Market, 2018 - 2030 (USD Million)
  • 4.5. Hydrogel-Coated Coils
    • 4.5.1. Hydrogel-Coated Coils Market, 2018 - 2030 (USD Million)

Chapter 5. Neuroendovascular Coil Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cerebral Infarction
    • 5.4.1. Cerebral Infarction Market, 2018 - 2030 (USD Million)
  • 5.5. Cerebral Aneurysm
    • 5.5.1. Cerebral Aneurysm Market, 2018 - 2030 (USD Million)
  • 5.6. Arteriovenous Malformation (AVM)
    • 5.6.1. Arteriovenous Malformation (AVM) Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuroendovascular Coil Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgery Centers
    • 6.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Specialty Clinics
    • 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Neuroendovascular Coil Market: Regional Estimates & Trend Analysis by Technology and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Share Analysis, 2024
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Penumbra, Inc
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. TERUMO CORPORATION
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Kaneka Medical Europe N.V.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Stryker
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Lepu Medical Technology (Beijing) Co.,Ltd
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Balt
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. NeuroSafe Medical Co., Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Johnson & Johnson
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Medtronic
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives